Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
9.08
+0.25 (2.83%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Replimune Group Employees
Replimune Group had 331 employees as of March 31, 2024. The number of employees increased by 47 or 16.55% compared to the previous year.
Employees
331
Change (1Y)
47
Growth (1Y)
16.55%
Revenue / Employee
n/a
Profits / Employee
-$689,553
Market Cap
699.29M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
REPL News
- 13 days ago - Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Replimune: A Misunderstood Contender In Oncolytics - Seeking Alpha
- 2 months ago - Replimune Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 months ago - Replimune to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 5 months ago - Replimune: RPL1 BLA Submission Under AA Pathway Makes It A Must Watch - Seeking Alpha
- 5 months ago - Replimune Announces Pricing of Upsized Public Offering - GlobeNewsWire
- 5 months ago - Replimune Announces Proposed Public Offering - GlobeNewsWire